[HTML][HTML] Measuring anti–factor Xa activity to monitor low-molecular-weight heparin in obesity: a critical review
G Egan, MHH Ensom - The Canadian journal of hospital pharmacy, 2015 - ncbi.nlm.nih.gov
Background: The choice of whether to monitor anti–factor Xa (anti-Xa) activity in patients
who are obese and who are receiving low-molecular-weight heparin (LMWH) therapy is …
who are obese and who are receiving low-molecular-weight heparin (LMWH) therapy is …
Disease burden and unmet needs for prevention of venous thromboembolism in medically ill patients in Europe show underutilisation of preventive therapies
H Khoury, S Welner, M Kubin… - Thrombosis and …, 2011 - thieme-connect.com
It was the aim of this review to assess the incidence of venous thromboembolism (VTE) and
current practice patterns for VTE prophylaxis among medical patients with acute illness in …
current practice patterns for VTE prophylaxis among medical patients with acute illness in …
The incidence of deep venous thrombosis in Parkinson's disease
Introduction Venous thromboembolism is one of the causes of sudden death in Parkinson's
Disease (PD). Few studies have investigated the correlation between PD and deep venous …
Disease (PD). Few studies have investigated the correlation between PD and deep venous …
Postural abnormality as a risk marker for leg deep venous thrombosis in Parkinson's disease
K Yamane, F Kimura, K Unoda, T Hosokawa, T Hirose… - PLoS …, 2013 - journals.plos.org
Background Pulmonary thromboembolism is a common cause of death in patients with
autopsy-confirmed Parkinsonism. This study investigated the incidence of leg deep vein …
autopsy-confirmed Parkinsonism. This study investigated the incidence of leg deep vein …
Effect of compression devices on preventing deep vein thrombosis among adult trauma patients: a systematic review
Background: Trauma is the leading cause of death in Americans up to 44 years old each
year. Deep vein thrombosis (DVT) is a significant condition occurring in trauma, and …
year. Deep vein thrombosis (DVT) is a significant condition occurring in trauma, and …
“Tap and twist”: preventing deep vein thrombosis in neuroscience patients through foot and ankle range-of-motion exercises
J Palamone, S Brunovsky, M Groth… - Journal of …, 2011 - journals.lww.com
Neurosurgical patients tend to have the highest rate of deep vein thrombosis (DVT) rate
among other postsurgical patients. The methods and timing of DVT prevention and treatment …
among other postsurgical patients. The methods and timing of DVT prevention and treatment …
Venous thromboembolism in neurologic disease
MJ Schneck - Handbook of clinical neurology, 2014 - Elsevier
Patients with neurologic disease are at high risk of venous thromboembolism (VTE) because
of relative immobility. They are also at increased risk due to the presence of a …
of relative immobility. They are also at increased risk due to the presence of a …
VTE prophylaxis in pregnant people with chronic physical disability: Data from a physicians survey and the need for guidance
S Kazi, A McLeod, A Berndl - Obstetric Medicine, 2023 - journals.sagepub.com
Background International guidelines recommend risk assessment during the antepartum
and postpartum period to inform VTE prophylaxis. We aimed to evaluate physicians' …
and postpartum period to inform VTE prophylaxis. We aimed to evaluate physicians' …
Other physical consequences of disability
J Macfarlane - Handbook of Clinical Neurology, 2013 - Elsevier
Prevention of secondary complications of neurological disease is important in minimizing
impairment and maximizing the long-term activity and participation of individuals. Immobility …
impairment and maximizing the long-term activity and participation of individuals. Immobility …
Prolonged thromboprophylaxis with enoxaparin in early neurological rehabilitation
A Lang, C Kienitz, P Wetzel… - Clinical and Applied …, 2011 - journals.sagepub.com
Prevention of venous thromboembolism (VTE) is essential in neurological patients. Little is
known about the optimal duration, efficacy, and safety of prolonged off-label use of low …
known about the optimal duration, efficacy, and safety of prolonged off-label use of low …